WO170
WO170 is a KCNT1 inhibitor that can be used in studies related to diseases associated with KCNT1 dysfunction, such as epilepsy.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 3109711-34-1
- 分子式: C25H21N5O
- 分子量:407.47
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
WO170 (I‑1a) is a KCNT1 channel inhibitor, with an IC50 ≤ 250 nM in the FLIPR thallium flux functional inhibition assay performed on HEK293 cells stably expressing human KCNT1[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
化学情報
-
CAS 番号 3109711-34-1
-
分子量 407.47
-
分子式 C25H21N5O
-
SMILES
N#CC1=CC2=C(N[C@H]3CCCC4=C3N=C(O4)C5=CC(C6CC6)=NC=C5)N=CC=C2C=C1
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
- WO170
- 3109711-34-1
- WO 170
- WO-170
- Drug Derivative
- refractory epilepsy
- post-traumatic epilepsy
- focal epilepsy
- infantile epilepsy with migrating focal seizures
- KCNT1
- generalized epilepsy
- sleep-related hypermotor epilepsy
- autosomal dominant nocturnal frontal lobe epilepsy
- epilepsy
- epileptic encephalopathy
- Inhibitor
- inhibitor
- inhibit